Cathie Wood ARK Investment Management
Cathie Wood is the founder, CEO, and CIO of ARK Investment Management, an investment firm known for its focus on “disruptive innovation”. She gained widespread attention for her bold market calls and high conviction in cutting-edge technologies such as electric vehicles, genomics, and blockchain. Under her guidance, ARK’s exchange-traded funds (ETFs) attracted substantial interest from both retail and institutional investors. Wood’s investment philosophy emphasizes research-driven analysis and long-term growth potential, positioning her as one of today’s most influential voices in the world of finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$12.5M |
| 2 |
Tesla
TSLA
|
+$8.86M |
| 3 |
Apple
AAPL
|
+$7.99M |
| 4 |
Stratasys
SSYS
|
+$7.51M |
| 5 |
RDFN
Redfin
RDFN
|
+$6.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
+$15.6M |
| 2 |
Qualcomm
QCOM
|
+$3.86M |
| 3 |
Baidu
BIDU
|
+$1.58M |
| 4 |
Protolabs
PRLB
|
+$771K |
| 5 |
IBM
IBM
|
+$706K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.19% |
| 2 | Healthcare | 23.79% |
| 3 | Communication Services | 13.49% |
| 4 | Consumer Discretionary | 10.43% |
| 5 | Industrials | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Box
BOX
$4.56B
| $994K | 0.12% |
51,438
+25,673
| +100% | +$482K |
|
|
MLNX
77
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $992K | 0.12% |
21,045
+7,008
| +50% | +$318K |
|
|
CFMS
78
DELISTED
Conformis, Inc. Common Stock
CFMS
| $955K | 0.12% |
10,848
+3,153
| +41% | +$312K |
|
79
Flex
FLEX
$40.8B
| $911K | 0.11% |
72,924
+20,685
| +40% | +$255K |
|
80
Inovio Pharmaceuticals
INO
$122M
| $909K | 0.11% |
11,949
+6,457
| +118% | +$480K |
|
|
FPRX
81
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $900K | 0.11% |
22,004
+7,830
| +55% | +$246K |
|
82
Agios Pharmaceuticals
AGIO
$1.98B
| $894K | 0.11% |
13,399
+2,686
| +25% | +$161K |
|
83
Plug Power
PLUG
$3.17B
| $881K | 0.11% |
337,457
+143,024
| +74% | +$319K |
|
84
JD.com
JD
$39.7B
| $851K | 0.1% |
+22,272
| New | +$953K |
|
85
Incyte
INCY
$25.9B
| $838K | 0.1% |
7,179
+3,268
| +84% | +$413K |
|
86
Rockwell Automation
ROK
$48.5B
| $836K | 0.1% |
4,690
+1,281
| +38% | +$213K |
|
87
General Motors
GM
$77.2B
| $828K | 0.1% |
20,517
+3,690
| +22% | +$135K |
|
88
Albemarle
ALB
$16.9B
| $811K | 0.1% |
5,953
-415
| -7% | -$49.3K |
|
|
UCTT
89
Ultra Clean Holdings
UCTT
$3.46B
| $784K | 0.1% |
25,611
+1,051
| +4% | +$24.8K |
|
|
90
Qualcomm
QCOM
$169B
| $777K | 0.09% |
14,982
-73,040
| -83% | -$3.86M |
|
91
Allient
ALNT
$1.63B
| $742K | 0.09% |
43,913
+7,898
| +22% | +$138K |
|
92
United Parcel Service
UPS
$86.8B
| $657K | 0.08% |
5,468
+1,773
| +48% | +$202K |
|
93
Howmet Aerospace
HWM
$108B
| $616K | 0.08% |
32,296
+10,760
| +50% | +$206K |
|
94
Ametek
AME
$54.9B
| $511K | 0.06% |
7,741
+1,557
| +25% | +$98.4K |
|
95
Gilead Sciences
GILD
$181B
| $511K | 0.06% |
+6,305
| New | +$482K |
|
|
CLLS
96
Cellectis
CLLS
$342M
| $465K | 0.06% |
16,334
+12,296
| +305% | +$318K |
|
|
FARO
97
DELISTED
Faro Technologies
FARO
| $460K | 0.06% |
12,035
+2,165
| +22% | +$78.4K |
|
98
CRISPR Therapeutics
CRSP
$5.75B
| $457K | 0.06% |
25,555
+12,667
| +98% | +$230K |
|
|
JNCE
99
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $445K | 0.05% |
28,532
+16,600
| +139% | +$235K |
|
100
GE Aerospace
GE
$361B
| $437K | 0.05% |
3,773
-3,697
| -49% | -$447K |
|
Similar funds
Cathie Wood's Q3 2017 Portfolio in Review
As of Q3 2017, Cathie Wood held 148 positions worth $819M, up 60% from $514M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Cathie Wood deployed $233M of net new capital in Q3 2017, opening 39 new positions and adding to 95 existing holdings. Its largest new stake was Redfin: 266,290 shares worth $6.68M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Kite Pharma, Inc., an estimated $15.6M trimmed.
- Cathie Wood's largest Q3 2017 buy was Redfin: 266,290 shares worth $6.68M.
- Cathie Wood added most to Twitter, Inc. in Q3 2017, an estimated $12.5M increase.
- Cathie Wood's biggest Q3 2017 reduction was Kite Pharma, Inc., cutting an estimated $15.6M.
- Cathie Wood fully exited IBM in Q3 2017, selling an estimated $706K.
- Cathie Wood's ten largest holdings make up 34% of its $819M portfolio in Q3 2017.
- Cathie Wood opened 39 new positions and closed 3 in Q3 2017.
- Cathie Wood's portfolio value rose 60% quarter-over-quarter to $819M.
Based on ARK Investment Management's 13F filing for Q3 2017, filed 9 Nov 2017.